Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

SFI reported for 6 months of 2024 by RAS

7/30/24 SFIN

Aeroflot reported for 6 months of 2024 by RAS

7/30/24 AFLT

Rosseti Center and Volga Region reported for 6 months of 2024 by RAS

7/30/24 MRKP

Rosseti Center reported for 6 months of 2024 by RAS

7/30/24 MRKC

Kaluga Sales Company reported for 6 months of 2024 by RAS

7/30/24 KLSB

UTair reports for 6 months of 2024 under RAS

7/30/24 UTAR

VTB reported for 6 months of 2024 by IFRS

7/30/24 VTBR

Yandex will start paying dividends

7/30/24 YDEX

Yandex reported for 6 months of 2024 by IFRS

7/30/24 YDEX

Kamchatskenergo reported for 6 months of 2024 by RAS

7/30/24 KCHE